Bill Aims To Create Approval Process For Biosimilars

Law360, New York (March 11, 2009, 12:00 AM EDT) -- A bipartisan group of lawmakers has introduced a bill that would create a regulatory process allowing the U.S. Food and Drug Administration to approve affordable generic versions of biologic drugs.

H.R. 1427, the “Promoting Innovation and Access to Life-Saving Medicine Act,” aims to give the FDA the power to authorize an approved copy of a biologic drug, and assure consumers that it is just as safe as the original product. It was introduced by Rep. Henry Waxman, D-Calif., chairman of the House Committee on Energy and...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.